Clinical Trial Update: PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease

View source ↗

Summary

A clinical trial examining PET/CT to predict response to infliximab in Crohn's disease was terminated before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Crohn's Disease | Status: TERMINATED